Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Luca Paglialunga
Osimertinib in Patients With Advanced Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer: Rationale, Evidence and Place in Therapy
Therapeutic Advances in Medical Oncology
Oncology
Related publications
Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation
Cancers
Cancer Research
Oncology
Combining Chemotherapy With Epidermal Growth Factor Receptor Inhibition in Advanced Non-Small Cell Lung Cancer
Therapeutic Advances in Medical Oncology
Oncology
Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Correction: Real-World Management of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small-Cell Lung Cancer in the USA
PLoS ONE
Multidisciplinary
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Elderly Patients With Advanced Non-Small Cell Lung Cancer
Current Gerontology and Geriatrics Research
Gerontology
Geriatrics
Cell Free Tumoral DNA Versus Paraffin Block Epidermal Growth Factor Receptor Mutation Detection in Patients With Non-Small Cell Lung Cancer
Asian Pacific Journal of Cancer Prevention
Efficacy, Safety, and Resistance Profile of Osimertinib in T790M Mutation-Positive Non-Small Cell Lung Cancer in Real-World Practice
PLoS ONE
Multidisciplinary
P2.13-22 Resistant Patterns to Osimertinib in Non-Small Cell Lung Cancer Patients With Both T790M and Sensitizing EGFR Mutation
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Cost‐Effectiveness of Osimertinib in Treating Newly Diagnosed, Advanced EGFR‐Mutation‐Positive Non‐Small Cell Lung Cancer
Oncologist
Cancer Research
Medicine
Oncology
